Activity value 76algeria Buyer,Last transaction date:
2025-12-19
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for sarl evexia pharma from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 21 transactions, with a transaction quantity of 2063.1 and a transaction weight of 0.
5lupin ltd
russiasupplier,they trade on 2019-07-06
10.64%
>
+View All
Products
Total 71
ProductsTransactionsPerDetail
food supplement 3167.39%>
premix 3065.22%>
raw material 1123.91%>
mult 919.57%>
multivitamin 613.04%>
+View All
Hscode rank
Total 12
HSCode NameTransactionsPerDetail
HS 210690992963.04%>
HS 130219191226.09%>
HS 3004901112.17%>
HS 3003902112.17%>
HS 3404909012.17%>
+View All
Trading Area
Total 2
AreaTransactionsPerDetail
india15599.36%>
vietnam10.64%>
Port statistics
Total 3
Port NameTransactionsPerDetail
algiers11976.28%>
skikda ex philippev148.97%>
alger85.13%>
sarl evexia pharma is algeria Buyer,
and primarily engages in the import and export business of products such as food supplement,premix,raw material.
According to the 52wmb.com global trade database, as of 2025-12-19, the company has completed 156 international trades,
with its main trading regions covering india,vietnam etc.
The core products include HS21069099,HS13021919,HS30049011 etc,
often transported via algiers,port skikda ex philippev, port alger etc,
and its main trading partners are octavius pharma pvt ltd.,anaha lifecare llp,ima pg india pvt.ltd.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sarl evexia pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.